8919 related articles for article (PubMed ID: 10338332)
21. Interleukin 15 induction of lymphokine-activated killer cell function against autologous tumor cells in melanoma patient lymphocytes by a CD18-dependent, perforin-related mechanism.
Gamero AM; Ussery D; Reintgen DS; Puleo CA; Djeu JY
Cancer Res; 1995 Nov; 55(21):4988-94. PubMed ID: 7585540
[TBL] [Abstract][Full Text] [Related]
22. Increased lysis of melanoma by in vivo-elicited human lymphokine-activated killer cells after addition of antiganglioside antibodies in vitro.
Harel W; Shau H; Hadley CG; Morgan AC; Reisfeld RA; Cheresh DA; Mitchell MS
Cancer Res; 1990 Oct; 50(19):6311-5. PubMed ID: 2400994
[TBL] [Abstract][Full Text] [Related]
23. Up-regulation of intercellular adhesion molecule 1 (ICAM-1) on human renal cell carcinoma cells by interleukin-4.
Obiri NI; Tandon N; Puri RK
Int J Cancer; 1995 May; 61(5):635-42. PubMed ID: 7768636
[TBL] [Abstract][Full Text] [Related]
24. Interleukin-7 induces differential lymphokine-activated killer cell activity against human melanoma cells, keratinocytes, and endothelial cells.
Schadendorf D; Böhm M; Möller P; Grünewald T; Czarnetzki BM
J Invest Dermatol; 1994 Jun; 102(6):838-42. PubMed ID: 8006445
[TBL] [Abstract][Full Text] [Related]
25. Target lysis by human LAK cells is critically dependent upon target binding properties, but LFA-1, LFA-3 and ICAM-1 are not the major adhesion ligands on targets.
Quillet-Mary A; Cavarec L; Kermarrec N; Marchiol-Fournigault C; Gil ML; Conjeaud H; Fradelizi D
Int J Cancer; 1991 Feb; 47(3):473-9. PubMed ID: 1704356
[TBL] [Abstract][Full Text] [Related]
26. Neutrophils influence melanoma adhesion and migration under flow conditions.
Slattery MJ; Dong C
Int J Cancer; 2003 Sep; 106(5):713-22. PubMed ID: 12866031
[TBL] [Abstract][Full Text] [Related]
27. Heregulin induces increase in sensitivity of an erbB-2-overexpressing breast cancer cell type to lysis by lymphokine-activated killer cells.
Cardillo M; Yankelevich B; Mazumder A; Lupu R
Cancer Immunol Immunother; 1996 Sep; 43(1):19-25. PubMed ID: 8917631
[TBL] [Abstract][Full Text] [Related]
28. Induction of intercellular adhesion molecule 1 on small cell lung carcinoma cell lines by gamma-interferon enhances spontaneous and bispecific anti-CD3 x antitumor antibody-directed lymphokine activated killer cell cytotoxicity.
Azuma A; Yagita H; Matsuda H; Okumura K; Niitani H
Cancer Res; 1992 Sep; 52(18):4890-4. PubMed ID: 1381273
[TBL] [Abstract][Full Text] [Related]
29. Pentoxifylline inhibits integrin-mediated adherence of interleukin-2- activated human peripheral blood lymphocytes to human umbilical vein endothelial cells, matrix components, and cultured tumor cells.
Kovach NL; Lindgren CG; Fefer A; Thompson JA; Yednock T; Harlan JM
Blood; 1994 Oct; 84(7):2234-42. PubMed ID: 7919341
[TBL] [Abstract][Full Text] [Related]
30. [Cytotoxicities of low dose anticancer agents combining lymphokine activated killer cell against ovarian adenocarcinoma cell line SKOV3].
Chen R; Pan L; Zhou S
Zhonghua Fu Chan Ke Za Zhi; 1999 Mar; 34(3):172-4. PubMed ID: 11263191
[TBL] [Abstract][Full Text] [Related]
31. Characterization of a highly invasive and spontaneously metastatic human malignant melanoma cell line.
Welch DR; Bisi JE; Miller BE; Conaway D; Seftor EA; Yohem KH; Gilmore LB; Seftor RE; Nakajima M; Hendrix MJ
Int J Cancer; 1991 Jan; 47(2):227-37. PubMed ID: 1671030
[TBL] [Abstract][Full Text] [Related]
32. Interferon-induced increase in sensitivity of ovarian cancer targets to lysis by lymphokine-activated killer cells: selective effects on HER2/neu-overexpressing cells.
Fady C; Gardner AM; Gera JF; Lichtenstein A
Cancer Res; 1992 Feb; 52(4):764-9. PubMed ID: 1346583
[TBL] [Abstract][Full Text] [Related]
33. Interferon-gamma induces a decrease in the susceptibility of human glioma cells to lysis by lymphokine-activated killer cells.
Yin D; Kondo S; Takeuchi J; Morimura T; Nakatsu S; Oda Y; Kikuchi H
Neurosurgery; 1994 Jul; 35(1):113-8. PubMed ID: 7936131
[TBL] [Abstract][Full Text] [Related]
34. Increased ICAM-1 expression in transformed human oral epithelial cells: molecular mechanism and functional role in peripheral blood mononuclear cell adhesion and lymphokine-activated-killer cell cytotoxicity.
Huang GT; Zhang X; Park NH
Int J Oncol; 2000 Sep; 17(3):479-86. PubMed ID: 10938387
[TBL] [Abstract][Full Text] [Related]
35. Transfection-induced tumor necrosis factor-alpha increases the susceptibility of human glioma cells to lysis by lymphokine-activated killer cells: continuous expression of intercellular adhesion molecule-1 on the glioma cells.
Takaoka T; Yoshida J; Mizuno M; Sugita K
Jpn J Cancer Res; 1994 Jul; 85(7):750-5. PubMed ID: 7915264
[TBL] [Abstract][Full Text] [Related]
36. Susceptibility of acute myelogenous leukemia blasts to lysis by lymphokine-activated killer (LAK) cells and its clinical relevance.
Archimbaud E; Thomas X; Campos L; Fiere D; Doré JF
Leuk Res; 1992; 16(6-7):673-80. PubMed ID: 1378919
[TBL] [Abstract][Full Text] [Related]
37. Influence of malignant cell clonogenic capacities and position along the maturation pathway on their susceptibility to lymphokine-activated killer cell cytotoxicity.
Thomas X; Anglaret B; Adeleine P; Maritaz O; Bailly M; Fiere D; Archimbaud E
Leuk Lymphoma; 1998 Jan; 28(3-4):343-53. PubMed ID: 9517505
[TBL] [Abstract][Full Text] [Related]
38. Human interleukin for DA cells/leukemia inhibitory factor and oncostatin M enhance membrane expression of intercellular adhesion molecule-1 on melanoma cells but not the shedding of its soluble form.
Heymann D; Godard A; Raher S; Ringeard S; Lassort D; Blanchard F; Harb J
Cytokine; 1995 Feb; 7(2):111-7. PubMed ID: 7780030
[TBL] [Abstract][Full Text] [Related]
39. Different susceptibility of cervical keratinocytes containing human papillomavirus to cell-mediated cytotoxicity.
Wu R; Coleman N; Stanley M
Chin Med J (Engl); 1996 Nov; 109(11):854-8. PubMed ID: 9275369
[TBL] [Abstract][Full Text] [Related]
40. 5-Fluorouracil increases susceptibility of renal cell cancer cell lines to lymphokine-activated killer cells: evidence for alteration not at the level of recognition but at a post-binding stage of the lytic cycle.
Tomita Y; Imai T; Katagiri A; Kimura M; Saitoh K; Sato S
Cancer Lett; 1993 Nov; 75(1):27-34. PubMed ID: 7904537
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
